[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Pediatric Anti-Flu Drugs Supply, Demand and Key Producers, 2023-2029

March 2023 | 97 pages | ID: G5F1415E8661EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Pediatric Anti-Flu Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Pediatric Anti-Flu Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Pediatric Anti-Flu Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pediatric Anti-Flu Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Pediatric Anti-Flu Drugs total production and demand, 2018-2029, (K Units)

Global Pediatric Anti-Flu Drugs total production value, 2018-2029, (USD Million)

Global Pediatric Anti-Flu Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Pediatric Anti-Flu Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Pediatric Anti-Flu Drugs domestic production, consumption, key domestic manufacturers and share

Global Pediatric Anti-Flu Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Pediatric Anti-Flu Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Pediatric Anti-Flu Drugs production by Sales Channel production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Pediatric Anti-Flu Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Johnson & Johnson, GlaxoSmithKline (GSK), Rostec and Cipla, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pediatric Anti-Flu Drugs market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Sales Channel. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Pediatric Anti-Flu Drugs Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Pediatric Anti-Flu Drugs Market, Segmentation by Type
  • Oseltamivir
  • Zanamivir
Global Pediatric Anti-Flu Drugs Market, Segmentation by Sales Channel
  • Hospital
  • Clinic
  • Online Sales
  • Others
Companies Profiled:
  • Roche
  • Johnson & Johnson
  • GlaxoSmithKline (GSK)
  • Rostec
  • Cipla
Key Questions Answered

1. How big is the global Pediatric Anti-Flu Drugs market?

2. What is the demand of the global Pediatric Anti-Flu Drugs market?

3. What is the year over year growth of the global Pediatric Anti-Flu Drugs market?

4. What is the production and production value of the global Pediatric Anti-Flu Drugs market?

5. Who are the key producers in the global Pediatric Anti-Flu Drugs market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Pediatric Anti-Flu Drugs Introduction
1.2 World Pediatric Anti-Flu Drugs Supply & Forecast
  1.2.1 World Pediatric Anti-Flu Drugs Production Value (2018 & 2022 & 2029)
  1.2.2 World Pediatric Anti-Flu Drugs Production (2018-2029)
  1.2.3 World Pediatric Anti-Flu Drugs Pricing Trends (2018-2029)
1.3 World Pediatric Anti-Flu Drugs Production by Region (Based on Production Site)
  1.3.1 World Pediatric Anti-Flu Drugs Production Value by Region (2018-2029)
  1.3.2 World Pediatric Anti-Flu Drugs Production by Region (2018-2029)
  1.3.3 World Pediatric Anti-Flu Drugs Average Price by Region (2018-2029)
  1.3.4 North America Pediatric Anti-Flu Drugs Production (2018-2029)
  1.3.5 Europe Pediatric Anti-Flu Drugs Production (2018-2029)
  1.3.6 China Pediatric Anti-Flu Drugs Production (2018-2029)
  1.3.7 Japan Pediatric Anti-Flu Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Pediatric Anti-Flu Drugs Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Pediatric Anti-Flu Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Pediatric Anti-Flu Drugs Demand (2018-2029)
2.2 World Pediatric Anti-Flu Drugs Consumption by Region
  2.2.1 World Pediatric Anti-Flu Drugs Consumption by Region (2018-2023)
  2.2.2 World Pediatric Anti-Flu Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Pediatric Anti-Flu Drugs Consumption (2018-2029)
2.4 China Pediatric Anti-Flu Drugs Consumption (2018-2029)
2.5 Europe Pediatric Anti-Flu Drugs Consumption (2018-2029)
2.6 Japan Pediatric Anti-Flu Drugs Consumption (2018-2029)
2.7 South Korea Pediatric Anti-Flu Drugs Consumption (2018-2029)
2.8 ASEAN Pediatric Anti-Flu Drugs Consumption (2018-2029)
2.9 India Pediatric Anti-Flu Drugs Consumption (2018-2029)

3 WORLD PEDIATRIC ANTI-FLU DRUGS MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Pediatric Anti-Flu Drugs Production Value by Manufacturer (2018-2023)
3.2 World Pediatric Anti-Flu Drugs Production by Manufacturer (2018-2023)
3.3 World Pediatric Anti-Flu Drugs Average Price by Manufacturer (2018-2023)
3.4 Pediatric Anti-Flu Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Pediatric Anti-Flu Drugs Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Pediatric Anti-Flu Drugs in 2022
  3.5.3 Global Concentration Ratios (CR8) for Pediatric Anti-Flu Drugs in 2022
3.6 Pediatric Anti-Flu Drugs Market: Overall Company Footprint Analysis
  3.6.1 Pediatric Anti-Flu Drugs Market: Region Footprint
  3.6.2 Pediatric Anti-Flu Drugs Market: Company Product Type Footprint
  3.6.3 Pediatric Anti-Flu Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Pediatric Anti-Flu Drugs Production Value Comparison
  4.1.1 United States VS China: Pediatric Anti-Flu Drugs Production Value Comparison (2018 & 2022 & 2029)
  4.1.2 United States VS China: Pediatric Anti-Flu Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Pediatric Anti-Flu Drugs Production Comparison
  4.2.1 United States VS China: Pediatric Anti-Flu Drugs Production Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Pediatric Anti-Flu Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Pediatric Anti-Flu Drugs Consumption Comparison
  4.3.1 United States VS China: Pediatric Anti-Flu Drugs Consumption Comparison (2018 & 2022 & 2029)
  4.3.2 United States VS China: Pediatric Anti-Flu Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Pediatric Anti-Flu Drugs Manufacturers and Market Share, 2018-2023
  4.4.1 United States Based Pediatric Anti-Flu Drugs Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers Pediatric Anti-Flu Drugs Production Value (2018-2023)
  4.4.3 United States Based Manufacturers Pediatric Anti-Flu Drugs Production (2018-2023)
4.5 China Based Pediatric Anti-Flu Drugs Manufacturers and Market Share
  4.5.1 China Based Pediatric Anti-Flu Drugs Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers Pediatric Anti-Flu Drugs Production Value (2018-2023)
  4.5.3 China Based Manufacturers Pediatric Anti-Flu Drugs Production (2018-2023)
4.6 Rest of World Based Pediatric Anti-Flu Drugs Manufacturers and Market Share, 2018-2023
  4.6.1 Rest of World Based Pediatric Anti-Flu Drugs Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers Pediatric Anti-Flu Drugs Production Value (2018-2023)
  4.6.3 Rest of World Based Manufacturers Pediatric Anti-Flu Drugs Production (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Pediatric Anti-Flu Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Oseltamivir
  5.2.2 Zanamivir
5.3 Market Segment by Type
  5.3.1 World Pediatric Anti-Flu Drugs Production by Type (2018-2029)
  5.3.2 World Pediatric Anti-Flu Drugs Production Value by Type (2018-2029)
  5.3.3 World Pediatric Anti-Flu Drugs Average Price by Type (2018-2029)

6 MARKET ANALYSIS BY SALES CHANNEL

6.1 World Pediatric Anti-Flu Drugs Market Size Overview by Sales Channel: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Sales Channel
  6.2.1 Hospital
  6.2.2 Clinic
  6.2.3 Online Sales
  6.2.4 Others
6.3 Market Segment by Sales Channel
  6.3.1 World Pediatric Anti-Flu Drugs Production by Sales Channel (2018-2029)
  6.3.2 World Pediatric Anti-Flu Drugs Production Value by Sales Channel (2018-2029)
  6.3.3 World Pediatric Anti-Flu Drugs Average Price by Sales Channel (2018-2029)

7 COMPANY PROFILES

7.1 Roche
  7.1.1 Roche Details
  7.1.2 Roche Major Business
  7.1.3 Roche Pediatric Anti-Flu Drugs Product and Services
  7.1.4 Roche Pediatric Anti-Flu Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.1.5 Roche Recent Developments/Updates
  7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Johnson & Johnson
  7.2.1 Johnson & Johnson Details
  7.2.2 Johnson & Johnson Major Business
  7.2.3 Johnson & Johnson Pediatric Anti-Flu Drugs Product and Services
  7.2.4 Johnson & Johnson Pediatric Anti-Flu Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.2.5 Johnson & Johnson Recent Developments/Updates
  7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.3 GlaxoSmithKline (GSK)
  7.3.1 GlaxoSmithKline (GSK) Details
  7.3.2 GlaxoSmithKline (GSK) Major Business
  7.3.3 GlaxoSmithKline (GSK) Pediatric Anti-Flu Drugs Product and Services
  7.3.4 GlaxoSmithKline (GSK) Pediatric Anti-Flu Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.3.5 GlaxoSmithKline (GSK) Recent Developments/Updates
  7.3.6 GlaxoSmithKline (GSK) Competitive Strengths & Weaknesses
7.4 Rostec
  7.4.1 Rostec Details
  7.4.2 Rostec Major Business
  7.4.3 Rostec Pediatric Anti-Flu Drugs Product and Services
  7.4.4 Rostec Pediatric Anti-Flu Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.4.5 Rostec Recent Developments/Updates
  7.4.6 Rostec Competitive Strengths & Weaknesses
7.5 Cipla
  7.5.1 Cipla Details
  7.5.2 Cipla Major Business
  7.5.3 Cipla Pediatric Anti-Flu Drugs Product and Services
  7.5.4 Cipla Pediatric Anti-Flu Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.5.5 Cipla Recent Developments/Updates
  7.5.6 Cipla Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Pediatric Anti-Flu Drugs Industry Chain
8.2 Pediatric Anti-Flu Drugs Upstream Analysis
  8.2.1 Pediatric Anti-Flu Drugs Core Raw Materials
  8.2.2 Main Manufacturers of Pediatric Anti-Flu Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Pediatric Anti-Flu Drugs Production Mode
8.6 Pediatric Anti-Flu Drugs Procurement Model
8.7 Pediatric Anti-Flu Drugs Industry Sales Model and Sales Channels
  8.7.1 Pediatric Anti-Flu Drugs Sales Model
  8.7.2 Pediatric Anti-Flu Drugs Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World Pediatric Anti-Flu Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Pediatric Anti-Flu Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Pediatric Anti-Flu Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Pediatric Anti-Flu Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Pediatric Anti-Flu Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Pediatric Anti-Flu Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Pediatric Anti-Flu Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Pediatric Anti-Flu Drugs Production Market Share by Region (2018-2023)
Table 9. World Pediatric Anti-Flu Drugs Production Market Share by Region (2024-2029)
Table 10. World Pediatric Anti-Flu Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Pediatric Anti-Flu Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Pediatric Anti-Flu Drugs Major Market Trends
Table 13. World Pediatric Anti-Flu Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Pediatric Anti-Flu Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Pediatric Anti-Flu Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Pediatric Anti-Flu Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Pediatric Anti-Flu Drugs Producers in 2022
Table 18. World Pediatric Anti-Flu Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Pediatric Anti-Flu Drugs Producers in 2022
Table 20. World Pediatric Anti-Flu Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Pediatric Anti-Flu Drugs Company Evaluation Quadrant
Table 22. World Pediatric Anti-Flu Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Pediatric Anti-Flu Drugs Production Site of Key Manufacturer
Table 24. Pediatric Anti-Flu Drugs Market: Company Product Type Footprint
Table 25. Pediatric Anti-Flu Drugs Market: Company Product Application Footprint
Table 26. Pediatric Anti-Flu Drugs Competitive Factors
Table 27. Pediatric Anti-Flu Drugs New Entrant and Capacity Expansion Plans
Table 28. Pediatric Anti-Flu Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Pediatric Anti-Flu Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Pediatric Anti-Flu Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Pediatric Anti-Flu Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Pediatric Anti-Flu Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Pediatric Anti-Flu Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Pediatric Anti-Flu Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Pediatric Anti-Flu Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Pediatric Anti-Flu Drugs Production Market Share (2018-2023)
Table 37. China Based Pediatric Anti-Flu Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Pediatric Anti-Flu Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Pediatric Anti-Flu Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Pediatric Anti-Flu Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Pediatric Anti-Flu Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Pediatric Anti-Flu Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Pediatric Anti-Flu Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Pediatric Anti-Flu Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Pediatric Anti-Flu Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Pediatric Anti-Flu Drugs Production Market Share (2018-2023)
Table 47. World Pediatric Anti-Flu Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Pediatric Anti-Flu Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Pediatric Anti-Flu Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Pediatric Anti-Flu Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Pediatric Anti-Flu Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Pediatric Anti-Flu Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Pediatric Anti-Flu Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Pediatric Anti-Flu Drugs Production Value by Sales Channel, (USD Million), 2018 & 2022 & 2029
Table 55. World Pediatric Anti-Flu Drugs Production by Sales Channel (2018-2023) & (K Units)
Table 56. World Pediatric Anti-Flu Drugs Production by Sales Channel (2024-2029) & (K Units)
Table 57. World Pediatric Anti-Flu Drugs Production Value by Sales Channel (2018-2023) & (USD Million)
Table 58. World Pediatric Anti-Flu Drugs Production Value by Sales Channel (2024-2029) & (USD Million)
Table 59. World Pediatric Anti-Flu Drugs Average Price by Sales Channel (2018-2023) & (US$/Unit)
Table 60. World Pediatric Anti-Flu Drugs Average Price by Sales Channel (2024-2029) & (US$/Unit)
Table 61. Roche Basic Information, Manufacturing Base and Competitors
Table 62. Roche Major Business
Table 63. Roche Pediatric Anti-Flu Drugs Product and Services
Table 64. Roche Pediatric Anti-Flu Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Roche Recent Developments/Updates
Table 66. Roche Competitive Strengths & Weaknesses
Table 67. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 68. Johnson & Johnson Major Business
Table 69. Johnson & Johnson Pediatric Anti-Flu Drugs Product and Services
Table 70. Johnson & Johnson Pediatric Anti-Flu Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Johnson & Johnson Recent Developments/Updates
Table 72. Johnson & Johnson Competitive Strengths & Weaknesses
Table 73. GlaxoSmithKline (GSK) Basic Information, Manufacturing Base and Competitors
Table 74. GlaxoSmithKline (GSK) Major Business
Table 75. GlaxoSmithKline (GSK) Pediatric Anti-Flu Drugs Product and Services
Table 76. GlaxoSmithKline (GSK) Pediatric Anti-Flu Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. GlaxoSmithKline (GSK) Recent Developments/Updates
Table 78. GlaxoSmithKline (GSK) Competitive Strengths & Weaknesses
Table 79. Rostec Basic Information, Manufacturing Base and Competitors
Table 80. Rostec Major Business
Table 81. Rostec Pediatric Anti-Flu Drugs Product and Services
Table 82. Rostec Pediatric Anti-Flu Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Rostec Recent Developments/Updates
Table 84. Cipla Basic Information, Manufacturing Base and Competitors
Table 85. Cipla Major Business
Table 86. Cipla Pediatric Anti-Flu Drugs Product and Services
Table 87. Cipla Pediatric Anti-Flu Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 88. Global Key Players of Pediatric Anti-Flu Drugs Upstream (Raw Materials)
Table 89. Pediatric Anti-Flu Drugs Typical Customers
Table 90. Pediatric Anti-Flu Drugs Typical Distributors

LIST OF FIGURES

Figure 1. Pediatric Anti-Flu Drugs Picture
Figure 2. World Pediatric Anti-Flu Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pediatric Anti-Flu Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Pediatric Anti-Flu Drugs Production (2018-2029) & (K Units)
Figure 5. World Pediatric Anti-Flu Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Pediatric Anti-Flu Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Pediatric Anti-Flu Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Pediatric Anti-Flu Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Pediatric Anti-Flu Drugs Production (2018-2029) & (K Units)
Figure 10. China Pediatric Anti-Flu Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Pediatric Anti-Flu Drugs Production (2018-2029) & (K Units)
Figure 12. Pediatric Anti-Flu Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Pediatric Anti-Flu Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Pediatric Anti-Flu Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Pediatric Anti-Flu Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Pediatric Anti-Flu Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Pediatric Anti-Flu Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Pediatric Anti-Flu Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Pediatric Anti-Flu Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Pediatric Anti-Flu Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Pediatric Anti-Flu Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Pediatric Anti-Flu Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Pediatric Anti-Flu Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Pediatric Anti-Flu Drugs Markets in 2022
Figure 26. United States VS China: Pediatric Anti-Flu Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Pediatric Anti-Flu Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pediatric Anti-Flu Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Pediatric Anti-Flu Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Pediatric Anti-Flu Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Pediatric Anti-Flu Drugs Production Market Share 2022
Figure 32. World Pediatric Anti-Flu Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Pediatric Anti-Flu Drugs Production Value Market Share by Type in 2022
Figure 34. Oseltamivir
Figure 35. Zanamivir
Figure 36. World Pediatric Anti-Flu Drugs Production Market Share by Type (2018-2029)
Figure 37. World Pediatric Anti-Flu Drugs Production Value Market Share by Type (2018-2029)
Figure 38. World Pediatric Anti-Flu Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Pediatric Anti-Flu Drugs Production Value by Sales Channel, (USD Million), 2018 & 2022 & 2029
Figure 40. World Pediatric Anti-Flu Drugs Production Value Market Share by Sales Channel in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Online Sales
Figure 44. Others
Figure 45. World Pediatric Anti-Flu Drugs Production Market Share by Sales Channel (2018-2029)
Figure 46. World Pediatric Anti-Flu Drugs Production Value Market Share by Sales Channel (2018-2029)
Figure 47. World Pediatric Anti-Flu Drugs Average Price by Sales Channel (2018-2029) & (US$/Unit)
Figure 48. Pediatric Anti-Flu Drugs Industry Chain
Figure 49. Pediatric Anti-Flu Drugs Procurement Model
Figure 50. Pediatric Anti-Flu Drugs Sales Model
Figure 51. Pediatric Anti-Flu Drugs Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source


More Publications